Graft-versus-leukemi-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia

Bone Marrow Transplantation

Volumn 26, Issue 11, 2000, Pages 1251-1254

  Howrey, R P ^a   Martin, P L ^a   Driscoll, T ^a   Szabolcs, P ^a   Kelly, T ^a   Shpall, E J ^b   Bearman, S I ^b   Slat Vasquez, V ^b   Rubinstein, P ^c   Stevens, C E ^c   Kurtzberg, J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NEW YORK BLOOD CENTER   (United States)

Author keywords

Acute leukemia; Graft versus luekemia; Umbilical cord blood

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CASE REPORT; FEMALE; FETUS BLOOD; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; REMISSION; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CANCER MORTALITY; CANCER RECURRENCE; CHEMOPROPHYLAXIS; CHRONIC DISEASE; DOSE RESPONSE; DRUG EFFICACY; ENTEROPATHY; FOLLOW UP; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HLA SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA REMISSION; PANCYTOPENIA; PRIORITY JOURNAL; SEIZURE; SKIN DISEASE; T CELL LEUKEMIA; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ADOLESCENT; FEMALE; FETAL BLOOD; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; REMISSION INDUCTION;

ASPARAGINASE; CD34 ANTIGEN; CD7 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; CYTOKINE; DAUNORUBICIN; DEXAMETHASONE; ERYTHROPOIETIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; HLA DR ANTIGEN; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENT; IMMUNOTOXIN; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VINCRISTINE;

EID: 0033625974     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702697     Document Type: Article

References (26)

1. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling
2. Transplantation of umbilical cord blood after myeloablative therapy: Analysis of engraftment
3. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients
4. Outcomes among 562 recipients of placental-blood transplants from unrelated donors
5. Antileukemic effects of graft versus host disease in human recipients of allogeneic marrow grafts
6. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation
7. Influence of acute and chronic graft-versus-host disease after relapse and survival after bone marrow transplantation from HLA identical siblings as treatment of acute and chronic leukemia
8. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia
9. Mechanisms of graft-versus-leukemia reaction
10. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk of relapse associated with T-cell depletion
11. Graft-versus-leukemia reactions after bone marrow transplantation
12. Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantation
13. Spontaneous complete remission and recovery of donor haemopoiesis without GVHD after relapse and apparent marrow graft rejection in poor-prognosis myelodysplastic syndrome
14. Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: Apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression
15. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
16. Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation
17. In vitro and in vivo assessment of the graft-versus-leukemia activity of cord blood
18. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells
19. Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation
20. Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy
21. T cell and NK cell mediated graft-versus-leukaemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukaemia
22. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: Relevance to umbilical cord blood transplantation
23. Two cytotoxic pathways of natural killer cells in human cord blood: Implications in cord blood transplantation
24. Post-bone marrow transplant use of immunotherapy
25. Effect of low-dose interleukin-2 on disease relapse after T-cell depleted allogeneic bone marrow transplantation
26. A phase I trial of augmentation of unrelated umbilical cord blood transplantation with ex vivo expanded cells